在癌症药物载体中针对STAT3的基于寡核酸的治疗方法很重要
Sara Molenda1,2, Agata Sikorska1,2, Anna Florczak1,2
1Department of Cancer Immunology, Poznan University of Medical Sciences, 15 Garbary St., 61-866 Poznan, Poland.
Cancers
|December 9, 2023
概括
橄核酸治疗方法为癌症中准信号传感器和转录激活器3 (STAT3) 提供了一种新的方法. 这些基于核酸的疗法,包括siRNA和ASO,在癌症治疗的临床前和临床研究中显示出前景.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 治疗方法 治疗方法
背景情况:
- 信号传感器和转录激活剂3 (STAT3) 在各种癌症中具有高度表达和酸化,与疾病进展和不良预后相关.
- 构成性STAT3激活驱动癌症特征如扩散,转移和耐药性,使其成为关键的治疗点.
- 现有的STAT3抑制剂由于上游反应和低特异性而面临限制.
研究的目的:
- 审查针对癌症中STAT3活性的基于寡核酸的治疗方法.
- 总结基于核酸的STAT3抑制对癌症治疗的影响.
- 突出传递载体在增强寡核酸有效性方面的作用.
主要方法:
- 对针对STAT3.3的基于寡核酸的治疗药物 (siRNA,shRNA,ASO,ODN-诱) 的临床前和临床研究的审查.
- 通过非编码核酸对STAT3通路调节的分析.
- 对基于纳米粒子的输送系统进行核酸治疗的评估.
主要成果:
- 基于橄核酸的治疗药物显示出在静止STAT3和修改癌症基因表达方面具有潜力.
- 研究表明,基于核酸的疗法对STAT3的抑制会影响各种癌症疗法.
- 输送系统,特别是功能化纳米颗粒,对于提高核酸治疗药物在癌细胞和瘤微环境中的疗效至关重要.
结论:
- 基于寡核酸的治疗方法是针对癌症中STAT3的有希望的策略.
- 有效的输送系统对于克服这些药物的局限性和最大限度地发挥这些药物的治疗潜力至关重要.
- 将特定的寡核酸与目标纳米颗粒结合起来,可以创建高效的抗癌配方.
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Tumor Immunotherapy
529
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
529
The JAK-STAT Signaling Pathway
8.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.9K


